Equities

Sarsys AB

SARS:NGM

Sarsys AB

Actions
  • Price (SEK)2.68
  • Today's Change0.02 / 0.75%
  • Shares traded9.50k
  • 1 Year change+58.58%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Sarsys AB grew revenues 22.96% from 35.28m to 43.38m while net income improved from a loss of 9.73m to a smaller loss of 5.55m.
Gross margin56.37%
Net profit margin-30.49%
Operating margin-27.33%
Return on assets-23.35%
Return on equity-247.30%
Return on investment-92.30%
More ▼

Cash flow in SEKView more

In 2023, Sarsys AB increased its cash reserves by 310.59%, or 792.00k. The company earned 8.41m from its operations for a Cash Flow Margin of 19.38%. In addition the company used 814.00k on investing activities and also paid 6.80m in financing cash flows.
Cash flow per share-0.5956
Price/Cash flow per share--
Book value per share0.0653
Tangible book value per share-0.638
More ▼

Balance sheet in SEKView more

Sarsys AB uses little or no debt in its capital structure.
Current ratio0.6545
Quick ratio0.3199
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in SEK

Year on year, growth in earnings per share excluding extraordinary items increased 42.97%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-43.89
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.